Medifast, Inc.

$12.56-0.20%($-0.03)
TickerSpark Score
58/100
Mixed
84
Valuation
40
Profitability
10
Growth
76
Health
80
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MED research report →

52-Week Range54% of range
Low $9.22
Current $12.56
High $15.46

Companymedifastinc.com

Medifast, Inc. , through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.

CEO
Daniel R. Chard
IPO
1993
Employees
504
HQ
Baltimore, MD, US

Price Chart

-9.97% · this period
$15.22$12.38$9.53May 20Nov 18May 20

Valuation

Market Cap
$139.71M
P/E
-6.91
P/S
0.40
P/B
0.70
EV/EBITDA
46.21
Div Yield
0.00%

Profitability

Gross Margin
70.12%
Op Margin
-4.06%
Net Margin
-5.78%
ROE
-9.68%
ROIC
-6.57%

Growth & Income

Revenue
$385.79M · -35.96%
Net Income
$-18,672,000 · -992.97%
EPS
$-1.70 · -994.74%
Op Income
$-14,213,000
FCF YoY
-92.66%

Performance & Tape

52W High
$15.46
52W Low
$9.22
50D MA
$10.87
200D MA
$11.86
Beta
0.57
Avg Volume
237.92K

Get TickerSpark's AI analysis on MED

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
May 11, 26SCHLACKMAN SCOTTbuy2,500
May 8, 26SCHLACKMAN SCOTTbuy2,500
Jan 5, 26Johnson Nicholas Markother0
Jan 5, 26Johnson Nicholas Markother0
Jan 5, 26Johnson Nicholas Markother0
Jan 5, 26Johnson Nicholas Markother0
Feb 7, 23Johnson Nicholas Markother22,640
Mar 25, 26MacKenzie Jonathan Barrettother10,830
Mar 13, 26MacKenzie Jonathan Barrettother198
Mar 17, 26MacKenzie Jonathan Barrettother70

Our MED Coverage

We haven't published any research on MED yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate MED Report →

Similar Companies